Drug Eluting Stent Market Growth Forecast Through 2033
The global Drug Eluting Stent Market is witnessing significant expansion due to the increasing burden of cardiovascular diseases (CVDs), growing adoption of minimally invasive cardiac procedures, and continuous advancements in stent technologies. The market was estimated at USD 4.0 billion in 2025 and is projected to reach USD 6.7 billion by 2033, growing at a CAGR of 6.7% from 2026 to 2033. Drug eluting stents (DES) have transformed interventional cardiology by reducing restenosis rates and improving long-term patient outcomes compared to bare-metal stents. As healthcare systems worldwide continue prioritizing early cardiac intervention and precision-based treatment, the demand for advanced DES technologies is expected to accelerate substantially over the coming years. Rising Prevalence of Cardiovascular Diseases and Associated Risk Factors The growing prevalence of cardiovascular diseases remains the primary growth driver for the Drug Eluting Stent Market. Coronary artery disea...